UK markets closed

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
68.26+4.86 (+7.67%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 86.57B
Enterprise value 81.00B
Trailing P/E 68.95
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)15.61
Price/book (mrq)6.82
Enterprise value/revenue 14.70
Enterprise value/EBITDA 49.64

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-15.41%
S&P500 52-week change 321.08%
52-week high 388.00
52-week low 340.14
50-day moving average 369.23
200-day moving average 359.45

Share statistics

Avg vol (3-month) 310.48M
Avg vol (10-day) 38.89M
Shares outstanding 51.27B
Implied shares outstanding 61.27B
Float 8254.47M
% held by insiders 181.77%
% held by institutions 13.34%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41
Forward annual dividend yield 41.46%
Trailing annual dividend rate 30.32
Trailing annual dividend yield 30.50%
5-year average dividend yield 4N/A
Payout ratio 4101.01%
Dividend date 3N/A
Ex-dividend date 405 Jun 2023
Last split factor 21.4:1
Last split date 305 Jun 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 3.80%
Operating margin (ttm)14.33%

Management effectiveness

Return on assets (ttm)-0.04%
Return on equity (ttm)0.92%

Income statement

Revenue (ttm)3.38B
Revenue per share (ttm)2.68
Quarterly revenue growth (yoy)-73.90%
Gross profit (ttm)N/A
EBITDA 215.81M
Net income avi to common (ttm)128.47M
Diluted EPS (ttm)0.99
Quarterly earnings growth (yoy)-89.90%

Balance sheet

Total cash (mrq)5.83B
Total cash per share (mrq)4.64
Total debt (mrq)331.63M
Total debt/equity (mrq)2.55%
Current ratio (mrq)4.20
Book value per share (mrq)10.19

Cash flow statement

Operating cash flow (ttm)1.86B
Levered free cash flow (ttm)658.97M